Bruin Biometrics

Executive Summary

Bruin Biometrics (BBI) is a Los Angeles-based medical technology company pioneering the use of biometric sensors for early detection and prevention of chronic conditions, with an initial focus on pressure injuries (bedsores). The company's flagship product, the SEM Scanner, is a handheld, non-invasive device that measures sub-epidermal moisture (SEM) to identify pressure damage before it becomes visible on the skin. By combining a proprietary medical device with a digital health assistant, BBI enables proactive, data-driven care in hospitals and long-term care facilities. The SEM Scanner has received FDA clearance and is supported by multiple clinical studies demonstrating its ability to reduce hospital-acquired pressure injury rates by up to 50%. BBI is privately held and operates in a market driven by regulatory mandates and cost-saving initiatives, though adoption has been gradual due to budget constraints and workflow integration challenges. The company continues to build its evidence base and expand commercial partnerships to drive growth.

Upcoming Catalysts (preview)

• Q4 2026Expansion of Medicare/Medicaid reimbursement coverage for SEM scanning technology70% success
• Q3 2026Publication of pivotal multi-center clinical trial results reinforcing cost-effectiveness and outcomes80% success
• Q2 2026Strategic partnership with a major group purchasing organization (GPO) to expand hospital access60% success